Classification du CIRC des substances cancérogènes

Le CIRC (Centre international de recherche sur le cancer) classe les agents, mélanges et expositions en cinq catégories:

Catégorie 1 : cancérogène pour l’homme.

Les agents cancérogènes certains pour l’homme. Un agent (ou un mélange) peut être ajouté à cette liste lorsque les preuves de sa cancérogénicité pour l’homme sont insuffisantes mais qu’il existe des preuves suffisantes de sa cancérogénicité expérimentale pour les animaux de laboratoire et des indications fortes selon lesquelles l’agent (ou le mélange) agit sur les personnes exposées par un mécanisme cancérogène.

Catégorie 2A : cancérogène probable pour l’homme.

les agents (ou les mélanges) probablement Cancérogènes pour l’homme. Le classement d’un agent dans cette catégorie est préconisé lorsqu’il existe des indices concordants de sa cancérogénicité pour l’homme et des preuves suffisantes de cancérogénicité expérimentale chez les animaux de laboratoire.

Catégorie 2B : cancérogène possible pour l’homme.

La liste des cancérogènes du groupe 2B du CIRC répertorie toutes les substances, mélanges et circonstances d’exposition déjà évaluées et classées dans le Groupe 2B, celui des cancérogènes possibles pour l’homme, par le Centre international de recherche sur le cancer.

Catégorie 3 : inclassable quant à sa cancérogénicité pour l’homme.

Cette liste énumère toutes les substances, mélanges et circonstances d’exposition évaluées à ce jour et classées dans le Groupe 3 (inclassables quant à leur cancérogénicité pour l’Homme) du CIRC.

Catégorie 4 : probablement non cancérogène pour l’homme.

Une seule substance, le caprolactame, a été classée dans cette catégorie après évaluation de sa cancérogénicité par le CIRC.

Le caprolactame ou plus précisément l’ε-caprolactame est un lactame comprenant sept atomes dans son cycle. Il sert demonomère dans la synthèse du nylon-6.

 

 

AGENTS CLASSÉS PAR LES MONOGRAPHIES DU CIRC ^[1]Site web du CIRC, consulté le 10/02/2016.

Group 1	L’agent est cancérogène pour l’Homme	118 agents
Group 2A	L’agent est probablement cancérogène pour l’Homme	75
Group 2B	L’agent est peut-être cancérogène pour l’Homme	288
Group 3	L’agent est inclassable quant à sa cancérogénicité pour l’Homme	503
Group 4	L’agent n’est probablement pas cancérogène pour l’Homme	1

 

CAS N°	Agent	Groupe	Volume	Année	Informations supplémentaires
50-00-0	Formaldehyde	1	Sup 7, 62, 88, 100F	2012
50-06-6	Phenobarbital	2B	Sup 7, 79	2001
50-07-7	Mitomycin C	2B	10, Sup 7	1987
50-18-0 6055-19-2	Cyclophosphamide	1	26, Sup 7, 100A	2012
50-29-3	DDT (4,4′-Dichlorodiphenyltrichloroethane)	2A	Sup 7, 53, 113	In prep.
50-32-8	Benzo[a]pyrene	1	Sup 7, 92, 100F	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
50-33-9	Phenylbutazone	3	13, Sup 7	1987
50-41-9	Clomiphene citrate	3	21, Sup 7	1987
50-44-2	6-Mercaptopurine	3	26, Sup 7	1987
50-55-5	Reserpine	3	24, Sup 7	1987
50-76-0	Actinomycin D	3	10, Sup 7	1987
51-02-5	Pronetalol hydrochloride	3	13, Sup 7	1987
51-03-6	Piperonyl butoxide	3	30, Sup 7	1987
51-18-3	2,4,6-Tris(1-aziridinyl)-s-triazine	3	9, Sup 7	1987
51-21-8	5-Fluorouracil	3	26, Sup 7	1987
51-52-5	Propylthiouracil	2B	Sup 7, 79	2001
51-75-2	Nitrogen mustard	2A	9, Sup 7	1987
51-79-6	Ethyl carbamate (Urethane)	2A	7, Sup 7, 96	2010
52-01-7	Spironolactone	3	Sup 7, 79	2001
52-24-4	Thiotepa	1	Sup 7, 50, 100A	2012
52-46-0	Apholate	3	9, Sup 7	1987
52-68-6	Trichlorfon	3	30, Sup 7	1987
53-03-2	Prednisone	3	26, Sup 7	1987
53-70-3	Dibenz[a,h]anthracene	2A	Sup 7, 92	2010	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
54-05-7	Chloroquine	3	13, Sup 7	1987
54-31-9	Furosemide (Frusemide)	3	50	1990
54-85-3	Isonicotinic acid hydrazide (Isoniazid)	3	4, Sup 7	1987
55-18-5	N-Nitrosodiethylamine	2A	17, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55-98-1	1,4-Butanediol dimethanesulfonate (see Busulfan)
55-98-1	Busulfan	1	4, Sup 7, 100A	2012
55-98-1	Myleran (see Busulfan)
56-04-2	Methylthiouracil	2B	Sup 7, 79	2001
56-23-5	Carbon tetrachloride	2B	20, Sup 7, 71	1999
56-25-7	Cantharidin	3	10, Sup 7	1987
56-38-2	Parathion	2B	30, Sup 7, 112	In prep.
56-53-1	Diethylstilbestrol	1	21, Sup 7, 100A	2012
56-55-3	Benz[a]anthracene	2B	92, Sup 7	2010
56-75-7	Chloramphenicol	2A	Sup 7, 50	1990	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
57-06-7	Allyl isothiocyanate	3	73, Sup 7	1999
57-14-7	1,1-Dimethylhydrazine	2B	4, Sup 7, 71	1999
57-39-6	Tris(2-methyl-1-aziridinyl)phosphine oxide	3	9, Sup 7	1987
57-41-0	Phenytoin	2B	Sup 7, 66	1996
57-57-8	beta-Propiolactone	2B	4, Sup 7, 71	1999
57-68-1	Sulfamethazine	3	79	2001	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
57-74-9	Chlordane	2B	Sup 7, 53, 79	2001
57-88-5	Cholesterol	3	31, Sup 7	1987
58-08-2	Caffeine	3	51	1991
58-14-0	Pyrimethamine	3	13, Sup 7	1987
58-55-9	Theophylline	3	51	1991
58-89-9	Lindane (see also Hexachlorocyclohexanes)	1	113	In prep.
58-93-5	Hydrochlorothiazide	2B	50, 108	in prep
59-05-2	Methotrexate	3	26, Sup 7	1987
59-87-0	Nitrofural (Nitrofurazone)	3	50	1990
59-89-2	N-Nitrosomorpholine	2B	17, Sup 7	1987
60-09-3	para-Aminoazobenzene	2B	8, Sup 7	1987
60-11-7	para-Dimethylaminoazobenzene	2B	8, Sup 7	1987
60-35-5	Acetamide	2B	7, Sup 7, 71	1999
60-56-0	Methimazole	3	79	2001
60-57-1	Dieldrin	3	5, Sup 7	1987
61-57-4	Niridazole	2B	13, Sup 7	1987
61-82-5	Amitrole	3	79, Sup 7	2001	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
62-44-2	Phenacetin	1	24, Sup 7, 100A	2012	NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
62-50-0	Ethyl methanesulfonate	2B	7, Sup 7	1987
62-53-3	Aniline	3	27, Sup 7	1987
62-55-5	Thioacetamide	2B	7, Sup 7	1987
62-56-6	Thiourea	3	Sup 7, 79	2001
62-73-7	Dichlorvos	2B	Sup 7, 53	1991
62-75-9	N-Nitrosodimethylamine	2A	17, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
63-25-2	Carbaryl	3	12, Sup 7	1987
63-92-3	Phenoxybenzamine hydrochloride	2B	24, Sup 7	1987
64-17-5	Ethanol in alcoholic beverages	1	96, 100E	2012
64-67-5	Diethyl sulfate	2A	54, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-27-3	Methyl methanesulfonate	2A	7, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-75-1	Uracil mustard	2B	9, Sup 7	1987
67-20-9	Nitrofurantoin	3	50	1990
67-45-8	Furazolidone	3	31, Sup 7	1987
67-63-0	Isopropyl alcohol	3	15, Sup 7, 71	1999
67-66-3	Chloroform	2B	Sup 7, 73	1999
67-72-1	Hexachloroethane	2B	73	1999
68-12-2	Dimethylformamide	3	47, 71	1999
68-76-8	Tris(aziridinyl)-para-benzoquinone (Triaziquone)	3	9, Sup 7	1987
69-53-4	Ampicillin	3	50	1990
70-25-7	N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG)	2A	4, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
70-30-4	Hexachlorophene	3	20, Sup 7	1987
71-43-2	Benzene	1	29, Sup 7. 100F	2012
71-55-6	1,1,1-Trichloroethane	3	20, Sup 7, 71	1999
71-58-9	Medroxyprogesterone acetate	2B	21, Sup 7	1987
72-20-8	Endrin	3	5, Sup 7	1987
72-43-5	Methoxychlor	3	20, Sup 7	1987
72-57-1	Trypan blue	2B	8, Sup 7	1987
74-83-9	Methyl bromide	3	41, Sup 7, 71	1999
74-85-1	Ethylene	3	Sup 7, 60	1994
74-87-3	Methyl chloride	3	41, Sup 7, 71	1999
74-88-4	Methyl iodide	3	41, Sup 7, 71	1999
74-96-4	Bromoethane	3	52, 71	1999
75-00-3	Chloroethane	3	52, 71	1999
75-01-4	Vinyl chloride	1	Sup 7, 97, 100F	2012
75-02-5	Vinyl fluoride	2A	Sup 7, 63, 97	2008	NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride
75-07-0	Acetaldehyde	2B	36, Sup 7, 71	1999
75-07-0	Acetaldehyde associated with consumption of alcoholic beverages	1	100E	2012
75-09-2	Dichloromethane (Methylene chloride)	2A	Sup 7, 71, 110	In prep.
75-21-8	Ethylene oxide	1	Sup 7, 60, 97, 100F	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
75-25-2	Bromoform	3	52, 71	1999
75-27-4	Bromodichloromethane	2B	52, 71	1999
75-35-4	Vinylidene chloride	3	39, Sup 7, 71	1999
75-38-7	Vinylidene fluoride	3	39, Sup 7, 71	1999
75-45-6	Chlorodifluoromethane	3	41, Sup 7, 71	1999
75-52-5	Nitromethane	2B	77	2000
75-55-8	2-Methylaziridine (Propyleneimine)	2B	9, Sup 7, 71	1999
75-56-9	Propylene oxide	2B	Sup 7, 60	1994
75-60-5	Dimethylarsinic acid	2B	100C	2012
75-87-6	Chloral	2A	63, 84, 106	2014
75-88-7	2-Chloro-1,1,1-trifluoroethane	3	41, Sup 7, 71	1999
76-01-7	Pentachloroethane	3	41, Sup 7, 71	1999
76-03-9	Trichloroacetic acid	2B	63, 84, 106	2014
76-44-8	Heptachlor	2B	Sup 7, 53, 79	2001
77-09-8	Phenolphthalein	2B	76	2000
77-78-1	Dimethyl sulfate	2A	4, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
78-79-5	Isoprene	2B	60, 71	1999
78-87-5	1,2-Dichloropropane	1	41, Sup 7, 71, 110	In prep.
78-98-8	Methylglyoxal	3	51	1991
79-00-5	1,1,2-Trichloroethane	3	52, 71	1999
79-01-6	Trichloroethylene	1	Sup 7, 63, 106	2014
79-06-1	Acrylamide	2A	60, Sup 7	1994	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-10-7	Acrylic acid	3	19, Sup 7, 71	1999
79-34-5	1,1,2,2-Tetrachloroethane	2B	20, Sup 7, 71, 106	2014
79-43-6	Dichloroacetic acid	2B	63, 84, 106	2014
79-44-7	Dimethylcarbamoyl chloride	2A	12, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-46-9	2-Nitropropane	2B	29, Sup 7, 71	1999
80-08-0	Dapsone	3	24, Sup 7	1987
80-62-6	Methyl methacrylate	3	Sup 7, 60	1994
81-07-2	Saccharin and its salts	3	Sup 7, 73	1999	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
81-15-2	Musk xylene	3	65	1996
81-49-2	1-Amino-2,4-dibromoanthraquinone	2B	101	2013
81-88-9	Rhodamine B	3	16, Sup 7	1987
82-28-0	1-Amino-2-methylanthraquinone	3	27, Sup 7	1987
82-68-8	Quintozene (Pentachloronitrobenzene)	3	5, Sup 7	1987
83-32-9	Acenaphthene	3	92	2010
83-63-6	Diacetylaminoazotoluene	3	8, Sup 7	1987
83-66-9	Musk ambrette	3	65	1996
83-67-0	Theobromine	3	51	1991
84-65-1	Anthraquinone	2B	101	2013
85-01-8	Phenanthrene	3	Sup 7, 92	2010
85-68-7	Butyl benzyl phthalate	3	Sup 7, 73	1999
85-83-6	Scarlet Red	3	8, Sup 7	1987
85-84-7	Yellow AB	3	8, Sup 7	1987
85-86-9	Sudan III	3	8, Sup 7	1987
86-30-6	N-Nitrosodiphenylamine	3	27, Sup 7	1987
86-54-4	Hydralazine	3	24, Sup 7	1987
86-57-7	1-Nitronaphthalene	3	46	1989
86-73-7	Fluorene	3	Sup 7, 92	2010
86-74-8	Carbazole	2B	32, Sup 7, 71, 103	2013
86-88-4	1-Naphthylthiourea (ANTU)	3	30, Sup 7	1987
87-29-6	Cinnamyl anthranilate	3	Sup 7, 77	2000
87-62-7	2,6-Dimethylaniline (2,6-Xylidine)	2B	57	1993
87-68-3	Hexachlorobutadiene	3	73	1999
87-86-5	Pentachlorophenol (see Polychlorophenols)		53, 71	1999
88-05-1	2,4,6-Trimethylaniline	3	27, Sup 7	1987
88-12-0	N-Vinyl-2-pyrrolidone	3	19, Sup 7, 71	1999
88-72-2	2-Nitrotoluene	2A	101	2013	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
88-73-3 121-73-3 100-00-5	Chloronitrobenzenes	3	65	1996
89-82-7	Pulegone	2B	108	In prep.
90-04-0	ortho-Anisidine	2B	Sup 7, 73	1999
90-43-7	ortho-Phenylphenol	3	73	1999
90-65-3	Penicillic acid	3	10, Sup 7	1987
90-94-8	Michler’s ketone [4,4´-Bis(dimethylamino)­benzophenone]	2B	99	2010
91-20-3	Naphthalene	2B	82	2002
91-23-6	2-Nitroanisole	2B	65	1996
91-59-8	2-Naphthylamine	1	4, Sup 7, 99, 100F	2012
91-64-5	Coumarin	3	Sup 7, 77	2000
91-93-0	3,3′-Dimethoxybenzidine-4,4′-diisocyanate	3	39, Sup 7	1987
91-94-1	3,3′-Dichlorobenzidine	2B	29, Sup 7	1987
92-67-1	4-Aminobiphenyl	1	1, Sup 7, 99, 100F	2012
92-87-5	Benzidine	1	29, Sup 7, 99, 100F	2012
92-93-3	4-Nitrobiphenyl	3	4, Sup 7	1987
93-15-2	Methyleugenol	2B	101	2013
94-36-0	Benzoyl peroxide	3	36, Sup 7, 71	1999
94-58-6	Dihydrosafrole	2B	10, Sup 7	1987
94-59-7	Safrole	2B	10, Sup 7	1987
94-75-7	2,4-D (2,4-dichlorophenoxyacetic acid) (See also Chlorophenoxy herbicides)	2B	113	In prep.
95-06-7	Sulfallate	2B	30, Sup 7	1987
95-50-1	ortho-Dichlorobenzene	3	Sup 7, 73	1999
95-53-4	ortho-Toluidine	1	Sup 7, 77, 99, 100F	2012
95-68-1	2,4-Xylidine	3	16, Sup 7	1987
95-69-2	4-Chloro-ortho-toluidine	2A	77, 99	2010
95-70-5	2,5-Diaminotoluene	3	16, Sup 7	1987
95-78-3	2,5-Xylidine	3	16, Sup 7	1987
95-79-4	5-Chloro-ortho-toluidine	3	77, 99	2010
95-80-7	2,4-Diaminotoluene	2B	16, Sup 7	1987
95-83-0	4-Chloro-ortho-phenylenediamine	2B	27, Sup 7	1987
96-09-3	Styrene-7,8-oxide	2A	Sup 7, 60	1994	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
96-12-8	1,2-Dibromo-3-chloropropane	2B	20, Sup 7, 71	1999
96-13-9	2,3-Dibromopropan-1-ol	2B	77	2000
96-18-4	1,2,3-Trichloropropane	2A	63	1995
96-23-1	1,3-Dichloro-2-propanol	2B	101	2013
96-24-2	3-Monochloro-1,2-propanediol	2B	101	2013
96-33-3	Methyl acrylate	3	39, Sup 7, 71	1999
96-45-7	Ethylenethiourea	3	Sup 7, 79	2001	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
96-48-0	gamma-Butyrolactone	3	11, Sup 7, 71	1999
97-53-0	Eugenol	3	36, Sup 7	1987
97-56-3	ortho-Aminoazotoluene	2B	8, Sup 7	1987
97-77-8	Disulfiram	3	12, Sup 7	1987
98-01-1	Furfural	3	63	1995
98-82-8	Cumene	2B	101	2013
98-83-9	a-Methylstyrene	2B	101	2013
98-87-3 98-07-7 100-44-7 98-88-4	alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures)	2A	29, Sup 7, 71	1999
98-95-3	Nitrobenzene	2B	65	1996
99-08-1 99-99-0	Nitrotoluenes	3	65	1996
99-55-8	5-Nitro-ortho-toluidine	3	48	1990
99-56-9	1,2-Diamino-4-nitrobenzene	3	16, Sup 7	1987
99-57-0	2-Amino-4-nitrophenol	3	57	1993
99-59-2	5-Nitro-ortho-anisidine	3	27, Sup 7	1987
99-80-9	N-Methyl-N,4-dinitrosoaniline	3	1, Sup 7	1987
100-40-3	4-Vinylcyclohexene	2B	Sup 7, 60	1994
100-41-4	Ethylbenzene	2B	77	2000
100-42-5	Styrene	2B	60, 82	2002
100-75-4	N-Nitrosopiperidine	2B	17, Sup 7	1987
101-14-4	4,4′-Methylenebis(2-chloroaniline) (MOCA)	1	Sup 7, 57, 99, 100F	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
101-21-3	Chloropropham	3	12, Sup 7	1987
101-25-7	Dinitrosopentamethylenetetramine	3	11, Sup 7	1987
101-61-1	Michler’s base [4,4´-methylenebis(N,N-dimethyl)­benzenamine]	2B	27, Sup 7, 99	2010
101-68-8	4,4′-Methylenediphenyl diisocyanate	3	19, Sup 7, 71	1999
101-77-9	4,4′-Methylenedianiline	2B	39, Sup 7	1987
101-80-4	4,4′-Diaminodiphenyl ether	2B	29, Sup 7	1987
101-90-6	Diglycidyl resorcinol ether	2B	36, Sup 7, 71	1999
102-50-1	meta-Cresidine	3	27, Sup 7	1987
102-71-6	Triethanolamine	3	77	2000
103-03-7	Phenicarbazide	3	12, Sup 7	1987
103-11-7	2-Ethylhexyl acrylate	3	60	1994
103-23-1	Di(2-ethylhexyl) adipate	3	Sup 7, 77	2000
103-33-3	Azobenzene	3	8, Sup 7	1987
103-90-2	Acetaminophen (see Paracetamol)
103-90-2	Paracetamol (Acetaminophen)	3	50, 73	1999
104-94-9	para-Anisidine	3	27, Sup 7	1987
105-11-3	para-Benzoquinone dioxime	3	29, Sup 7, 71	1999
105-55-5	N,N‘-Diethylthiourea	3	79	2001
105-60-2	Caprolactam	4	39, Sup 7, 71	1999
105-74-8	Lauroyl peroxide	3	36, Sup 7, 71	1999
106-46-7	para-Dichlorobenzene	2B	Sup 7, 73	1999
106-47-8	para-Chloroaniline	2B	57	1993
106-50-3	para-Phenylenediamine	3	16, Sup 7	1987
106-51-4	para-Quinone	3	15, Sup 7, 71	1999
106-87-6	4-Vinylcyclohexene diepoxide	2B	Sup 7, 60	1994
106-88-7	1,2-Epoxybutane	2B	47, 71	1999	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
106-89-8	Epichlorohydrin	2A	11, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-93-4	Ethylene dibromide	2A	15, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-99-0	1,3-Butadiene	1	Sup 7, 54, 71, 97, 100F	2012
107-02-8	Acrolein	3	63, Sup 7	1995
107-05-1	Allyl chloride	3	36, Sup 7, 71	1999
107-06-2	1,2-Dichloroethane	2B	20, Sup 7, 71	1999
107-13-1	Acrylonitrile	2B	71	1999
107-14-2	Chloroacetonitrile	3	52, 71	1999
107-30-2	Chloromethyl methyl ether (see Bis(chloromethyl)ether; chloromethyl methyl ether)
108-05-4	Vinyl acetate	2B	Sup 7, 63	1995
108-10-1	Methyl isobutyl ketone	2B	101	2013
108-30-5	Succinic anhydride	3	15, Sup 7	1987
108-45-2	meta-Phenylenediamine	3	16, Sup 7	1987
108-46-3	Resorcinol	3	15, Sup 7, 71	1999
108-60-1	Bis(2-chloro-1-methylethyl)ether	3	41, Sup 7, 71	1999
108-78-1	Melamine	3	Sup 7, 73	1999	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
108-88-3	Toluene	3	47, 71	1999
108-94-1	Cyclohexanone	3	47, 71	1999
108-95-2	Phenol	3	47, 71	1999
110-00-9	Furan	2B	63	1995
110-57-6	trans-1,4-Dichlorobutene	3	15, Sup 7, 71	1999
110-86-1	Pyridine	3	77	2000
110-91-8	Morpholine	3	47, 71	1999
111-42-2	Diethanolamine	2B	77, 101	2013
111-44-4	Bis(2-chloroethyl)ether	3	9, Sup 7, 71	1999
111-76-2	2-Butoxyethanol	3	88	2006
115-02-6	Azaserine	2B	10, Sup 7	1987
115-07-1	Propylene	3	Sup 7, 60	1994
115-28-6	Chlorendic acid	2B	48	1990
115-32-2	Dicofol	3	30, Sup 7	1987
115-96-8	Tris(2-chloroethyl) phosphate	3	48, 71	1999
116-06-3	Aldicarb	3	53	1991
116-14-3	Tetrafluoroethylene	2A	19, Sup 7, 71, 110	In prep.	NB: Overall evaluation upgraded to Group 2A on the basis of sufficient evidence in experimental animals with a striking and atypical pattern of tumours
117-10-2	Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)	2B	50	1990
117-39-5	Quercetin	3	Sup 7, 73	1999
117-79-3	2-Aminoanthraquinone	3	27, Sup 7	1987
117-81-7	Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) phthalate)
117-81-7	Di(2-ethylhexyl)phthalate	2B	Sup 7, 77, 101	2013
118-74-1	Hexachlorobenzene	2B	Sup 7, 79	2001
118-92-3	Anthranilic acid	3	16, Sup 7	1987
118-96-7	2,4,6-Trinitrotoluene	3	65	1996
119-34-6	4-Amino-2-nitrophenol	3	16, Sup 7	1987
119-61-9	Benzophenone	2B	101	2013
119-90-4	3,3′-Dimethoxybenzidine (ortho-Dianisidine)	2B	4, Sup 7	1987
119-93-7	3,3′-Dimethylbenzidine (ortho-Tolidine)	2B	1, Sup 7	1987
120-12-7	Anthracene	3	92, Sup 7	2010
120-58-1	Isosafrole	3	10, Sup 7	1987
120-71-8	para-Cresidine	2B	27, Sup 7	1987
120-80-9	Catechol	2B	15, Sup 7, 71	1999
121-14-2	2,4-Dinitrotoluene	2B	65	1996
121-66-4	2-Amino-5-nitrothiazole	3	31, Sup 7	1987
121-69-7	N,N-Dimethylaniline	3	57	1993
121-75-5	Malathion	2A	30, Sup 7, 112	In prep.
121-88-0	2-Amino-5-nitrophenol	3	57	1993
122-34-9	Simazine	3	53, 73	1999
122-42-9	Propham	3	12, Sup 7	1987
122-60-1	Phenyl glycidyl ether	2B	47, 71	1999
123-31-9	Hydroquinone	3	15, Sup 7, 71	1999
123-33-1	Maleic hydrazide	3	4, Sup 7	1987
123-91-1	1,4-Dioxane	2B	11, Sup 7, 71	1999
124-48-1	Chlorodibromomethane	3	52, 71	1999
124-58-3	Methylarsonic acid	2B	100C	2012
124-58-3	Monomethylarsonic acid (see Methylarsonic acid)	2B	100C	2012
125-33-7	Primidone	2B	108	In prep.
126-07-8	Griseofulvin	2B	Sup 7, 79	2001
126-72-7	Tris(2,3-dibromopropyl) phosphate	2A	20, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
126-85-2	Nitrogen mustard N-oxide	2B	9, Sup 7	1987
126-99-8	Chloroprene	2B	Sup 7, 71	1999
127-07-1	Hydroxyurea	3	76	2000
127-18-4	Tetrachloroethylene (Perchloroethylene)	2A	Sup 7, 63, 106	2014
127-69-5	Sulfafurazole (Sulfisoxazole)	3	24, Sup 7	1987
128-37-0	Butylated hydroxytoluene (BHT)	3	40, Sup 7	1987
128-66-5	Vat Yellow 4	3	48	1990
129-00-0	Pyrene	3	Sup 7, 92	2010
129-15-7	2-Methyl-1-nitroanthraquinone (uncertain purity)	2B	27, Sup 7	1987
129-17-9	Blue VRS	3	16, Sup 7	1987
129-20-4	Oxyphenbutazone	3	13, Sup 7	1987
129-43-1	1-Hydroxyanthraquinone	2B	82	2002
131-79-3	Yellow OB	3	8, Sup 7	1987
132-27-4	Sodium ortho-phenylphenate	2B	Sup 7, 73	1999
132-65-0	Dibenzothiophene	3	103	2013
133-06-2	Captan	3	30, Sup 7	1987
134-32-7	1-Naphthylamine	3	4, Sup 7	1987
135-88-6	N-Phenyl-2-naphthylamine	3	16, Sup 7	1987
136-40-3	Phenazopyridine hydrochloride	2B	24, Sup 7	1987
137-17-7	2,4,5-Trimethylaniline	3	27, Sup 7	1987
137-26-8	Thiram	3	Sup 7, 53	1991
137-30-4	Ziram	3	Sup 7, 53	1991
138-59-0	Shikimic acid	3	40, Sup 7	1987
139-05-9	Cyclamates (sodium cyclamate)	3	Sup 7, 73	1999
139-13-9	Nitrilotriacetic acid and its salts	2B	48, 73	1999	NB: Evaluated as a group
139-65-1	4,4′-Thiodianiline	2B	27, Sup 7	1987
139-94-6	Nithiazide	3	31, Sup 7	1987
140-11-4	Benzyl acetate	3	40, Sup 7, 71	1999
140-56-7	para-Dimethylaminoazobenzenediazo sodium sulfonate	3	8, Sup 7	1987
140-57-8	Aramite®	2B	5, Sup 7	1987
140-88-5	Ethyl acrylate	2B	39, Sup 7, 71	1999
141-32-2	n-Butyl acrylate	3	39, Sup 7, 71	1999
141-37-7	3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate	3	11, Sup 7, 71	1999
141-90-2	Thiouracil	2B	Sup 7, 79	2001
142-83-6	2,4-Hexadienal	2B	101	2013
143-50-0	Chlordecone (Kepone)	2B	20, Sup 7	1987
143-67-9	Vinblastine sulfate	3	26, Sup 7	1987
144-34-3	Methyl selenac	3	12, Sup 7	1987
148-18-5	Sodium diethyldithiocarbamate	3	12, Sup 7	1987
148-24-3	8-Hydroxyquinoline	3	13, Sup 7	1987
148-82-3	Melphalan	1	9, Sup 7, 100A	2012
149-29-1	Patulin	3	40, Sup 7	1987
150-13-0	para-Aminobenzoic acid	3	16, Sup 7	1987
150-68-5	Monuron	3	Sup 7, 53	1991
150-69-6	Dulcin	3	12, Sup 7	1987
151-56-4	Aziridine	2B	9, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
154-93-8	Bischloroethyl nitrosourea (BCNU)	2A	26, Sup 7	1987
156-10-5	para-Nitrosodiphenylamine	3	27, Sup 7	1987
156-51-4	Phenelzine sulfate	3	24, Sup 7	1987
189-55-9	Dibenzo[a,i]pyrene	2B	92	2010
189-64-0	Dibenzo[a,h]pyrene	2B	Sup 7, 92	2010
191-07-1	Coronene	3	32, Sup 7, 92	1987
191-24-2	Benzo[ghi]perylene	3	92, Sup 7	2010
191-26-4	Anthanthrene	3	92, Sup 7	2010
191-30-0	Dibenzo[a,l]pyrene	2A	Sup 7, 92	2010	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
192-47-2	Dibenzo[h,rst]pentaphene	3	Sup 7, 92	2010
192-51-8	Dibenzo[e,l]pyrene	3	92	2010
192-65-4	Dibenzo[a,e]pyrene	3	Sup 7, 92	2010
192-97-2	Benzo[e]pyrene	3	92, Sup 7	2010
193-09-9	Naphtho[2,3-e]pyrene	3	92	2010
193-39-5	Indeno[1,2,3-cd]pyrene	2B	Sup 7, 92	2010
194-59-2	7H-Dibenzo[c,g]carbazole	2B	32, Sup 7, 103	2013
195-19-7	Benzo[c]phenanthrene	2B	92, Sup 7	2010	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
196-78-1	Benzo[g]chrysene	3	92	2010
198-55-0	Perylene	3	Sup 7, 92	2010
202-33-5	Benz[j]aceanthrylene	2B	92	2010	NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data
202-94-8	11H-Benz[bc]aceanthrylene	3	92	2010
202-98-2	4H-Cyclopenta[def]chrysene	3	92	2010
203-12-3	Benzo[ghi]fluoranthene	3	92, Sup 7	2010
203-20-3	Naphtho[2,1-a]fluoranthene	3	92	2010
203-33-8	Benzo[a]fluoranthene	3	92, Sup 7	2010
205-12-9	Benzo[c]fluorene	3	92, Sup 7	2010
205-82-3	Benzo[j]fluoranthene	2B	92	2010
205-99-2	Benzo[b]fluoranthene	2B	92	2010
206-44-0	Fluoranthene	3	Sup 7, 92	2010
207-08-9	Benzo[k]fluoranthene	2B	92	2010
207-83-0	13H-Dibenzo[a,g]fluorene	3	92	2010
211-91-6	Benz[l]aceanthrylene	3	92	2010
213-46-7	Picene	3	92	2010
214-17-5	Benzo[b]chrysene	3	92	2010
215-58-7	Dibenz[a,c]anthracene	3	Sup 7, 92	2010
217-59-4	Triphenylene	3	Sup 7, 92	2010
218-01-9	Chrysene	2B	92	2010
224-41-9	Dibenz[a,j]anthracene	3	Sup 7, 92	2010
224-42-0	Dibenz[a,j]acridine	2A	32, Sup 7, 103	2013	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
224-53-3	Dibenz[c,h]acridine	2B	103	2013	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
225-11-6	Benz[a]acridine	3	32, Sup 7, 103	2013
225-51-4	Benz[c]acridine	3	32, Sup 7, 103	2013
226-36-8	Dibenz[a,h]acridine	2B	32, Sup 7, 103	2013
238-84-6	Benzo[a]fluorene	3	92, Sup 7	2010
239-35-0	Benzo[b]naphtho[2,1-d]thiophene	3	103	2013
243-17-4	Benzo[b]fluorene	3	92, Sup 7	2010
262-12-4	Dibenzo-para-dioxin	3	69	1997
271-89-6	Benzofuran	2B	63	1995
298-00-0	Methyl parathion	3	30, Sup 7	1987
298-81-7	Methoxsalen (8-methoxypsoralen) plus ultraviolet A radiation	1	24, Sup 7, 100A	2012
299-75-2	Treosulfan	1	26, Sup 7, 100A	2012
302-01-2	Hydrazine	2B	4, Sup 7, 71	1999
302-17-0	Chloral hydrate	2A	63, 84, 106	2014
303-34-4	Lasiocarpine	2B	10, Sup 7	1987
303-47-9	Ochratoxin A	2B	Sup 7, 56	1993
305-03-3	Chlorambucil	1	26, Sup 7, 100A	2012
309-00-2	Aldrin	3	5, Sup 7	1987
313-67-7	Aristolochic acid	1	82, 100A	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
313-67-7	Aristolochic acid, plants containing	1	82, 100A	2012
314-13-6	Evans blue	3	8, Sup 7	1987
315-18-4	Zectran	3	12, Sup 7	1987
315-22-0	Monocrotaline	2B	10, Sup 7	1987
320-67-2	Azacitidine	2A	50	1990	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
331-39-5	Caffeic acid	2B	56	1993
333-41-5	Diazinon	2A	112	In prep.	NB: Overall evaluation upgraded to Group 2A based on mechanistic evidence
334-88-3	Diazomethane	3	7, Sup 7	1987
335-67-1	Perfluorooctanoic acid	2B	110	In prep.
366-70-1	Procarbazine hydrochloride	2A	26, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
396-01-0	Triamterene	2B	108	In prep.
420-12-2	Ethylene sulfide	3	11, Sup 7	1987
439-14-5	Diazepam	3	Sup 7, 66	1996
443-48-1	Metronidazole	2B	13, Sup 7	1987
446-86-6	Azathioprine	1	26, Sup 7, 100A	2012
480-54-6	Retrorsine	3	10, Sup 7	1987
480-81-9	Seneciphylline	3	10, Sup 7	1987
484-20-8	5-Methoxypsoralen	2A	40, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
492-17-1	2,4′-Diphenyldiamine	3	16, Sup 7	1987
492-80-8	Auramine	2B	1, Sup 7, 99, 100F	2012
493-52-7	Methyl red	3	8, Sup 7	1987
494-03-1	Chlornaphazine	1	4, Sup 7, 100A	2012
494-03-1	N,N-Bis(2-chloroethyl)-2-naphthylamine (see Chlornaphazine)
494-38-2	Acridine orange	3	16, Sup 7	1987
501-30-4	Kojic acid	3	79	2001
505-60-2	Mustard gas (see Sulfur mustard)
505-60-2	Sulfur mustard	1	9, Sup 7, 100F	2012
509-14-8	Tetranitromethane	2B	65	1996
510-15-6	Chlorobenzilate	3	30, Sup 7	1987
513-37-1	1-Chloro-2-methylpropene	2B	63	1995
518-75-2	Citrinin	3	40, Sup 7	1987
520-18-3	Kaempferol	3	31, Sup 7	1987
523-44-4	CI Acid Orange 20	3	8, Sup 7	1987
523-44-4	Orange I (see CI Acid Orange 20)
523-50-2	Angelicin plus ultraviolet A radiation	3	40, Sup 7	1987
531-76-0	Merphalan	2B	9, Sup 7	1987
531-82-8	N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide	2B	7, Sup 7	1987
532-82-1	Chrysoidine	3	8, Sup 7	1987
536-33-4	Ethionamide	3	13, Sup 7	1987
540-73-8	1,2-Dimethylhydrazine	2A	4, Sup 7, 71	1999	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
541-73-1	meta-Dichlorobenzene	3	73	1999
542-75-6	1,3-Dichloropropene (technical-grade)	2B	41, Sup 7, 71	1999
542-78-9	Malonaldehyde	3	36, Sup 7, 71	1999
542-88-1 107-30-2	Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade)	1	4, Sup 7, 100F	2012
545-06-2	Trichloroacetonitrile	3	52, 71	1999
545-55-1	Tris(1-aziridinyl)phosphine oxide	3	9, Sup 7	1987
551-74-6	Mannomustine dihydrochloride	3	9, Sup 7	1987
555-84-0	1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone	2B	7, Sup 7	1987
556-52-5	Glycidol	2A	77	2000	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
562-10-7	Doxylamine succinate	3	79	2001
563-41-7	Semicarbazide hydrochloride	3	12, Sup 7	1987
563-47-3	3-Chloro-2-methylpropene	3	63	1995
569-61-9	CI Basic Red 9	2B	57, 99	2010
581-89-5	2-Nitronaphthalene	3	46	1989
592-62-1	Methylazoxymethanol acetate	2B	10, Sup 7	1987
593-60-2	Vinyl bromide	2A	39, Sup 7, 71, 97	2008	NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride
593-70-4	Chlorofluoromethane	3	41, Sup 7, 71	1999
598-55-0	Methyl carbamate	3	12, Sup 7	1987
599-79-1	Sulfasalazine	2B	108	In prep.
602-60-8	9-Nitroanthracene	3	33, Sup 7	1987
602-87-9	5-Nitroacenaphthene	2B	16, Sup 7	1987
604-75-1	Oxazepam	2B	Sup 7, 66	1996
606-20-2	2,6-Dinitrotoluene	2B	65	1996
607-57-8	2-Nitrofluorene	2B	46, 105	2013
609-20-1	2,6-Dichloro-para-phenylenediamine	3	39, Sup 7	1987
613-35-4	N,N‘-Diacetylbenzidine	2B	16, Sup 7	1987
615-05-4	2,4-Diaminoanisole	2B	Sup 7, 79	2001
615-53-2	N-Methyl-N-nitrosourethane	2B	4, Sup 7	1987
618-85-9	3,5-Dinitrotoluene	3	65	1996
621-64-7	N-Nitrosodi-n-propylamine	2B	17, Sup 7	1987
627-12-3	n-Propyl carbamate	3	12, Sup 7	1987
630-20-6	1,1,1,2-Tetrachloroethane	2B	41, Sup 7, 71, 106	2014
631-64-1	Dibromoacetic acid	2B	101	2013
632-99-5	Magenta	2B	Sup 7, 57, 99, 100F	2012
637-07-0	Clofibrate	3	Sup 7, 66	1996
641-48-5	Dihydroaceanthrylene	3	92	2010
680-31-9	Hexamethylphosphoramide	2B	15, Sup 7, 71	1999
684-93-5	N-Methyl-N-nitrosourea	2A	17, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
693-98-1	2-Methylimidazole	2B	101	2013
712-68-5	2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole	2B	7, Sup 7	1987
723-46-6	Sulfamethoxazole	3	Sup 7, 79	2001
759-73-9	N-Ethyl-N-nitrosourea	2A	17, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
765-34-4	Glycidaldehyde	2B	11, Sup 7, 71	1999
789-07-1	2-Nitropyrene	3	46	1989
794-93-4	Dihydroxymethylfuratrizine (see also Panfuran S)	3	24, Sup 7	1987
794-93-4	Panfuran S (containing dihydroxymethylfuratrizine)	2B	24, Sup 7	1987
800-24-8	Aziridyl benzoquinone	3	9, Sup 7	1987
804-36-4	Nitrovin	3	31, Sup 7	1987
817-09-4	Trichlormethine (Trimustine hydrochloride)	2B	Sup 7, 50	1990
822-36-6	4-Methylimidazole	2B	101	2013
828-00-2	Dimethoxane	3	15, Sup 7	1987
832-69-9	1-Methylphenanthrene	3	Sup 7, 92	2010
838-88-0	4,4′-Methylene bis(2-methylaniline)	2B	4, Sup 7	1987
842-07-9	Sudan I	3	8, Sup 7	1987
846-50-4	Temazepam	3	66	1996
868-85-9	Dimethyl hydrogen phosphite	3	48, 71	1999
892-21-7	3-Nitrofluoranthene	3	33, Sup 7	1987
915-67-3	Amaranth	3	8, Sup 7	1987
924-16-3	N-Nitrosodi-n-butylamine	2B	17, Sup 7	1987
930-55-2	N-Nitrosopyrrolidine	2B	17, Sup 7	1987
989-38-8	Rhodamine 6G	3	16, Sup 7	1987
1071-83-6	Glyphosate	2A	112	In prep.
1072-52-2	2-(1-Aziridinyl)ethanol	3	9, Sup 7	1987
1116-54-7	N-Nitrosodiethanolamine	2B	17, Sup 7, 77	2000
1120-71-4	1,3-Propane sultone	2A	4, Sup 7, 71, 110	In prep.	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1143-38-0	Dithranol	3	13; Sup 7	1987
1163-19-5	Decabromodiphenyl oxide	3	48, 71	1999
1303-00-0	Gallium arsenide (see Arsenic and inorganic arsenic compounds)		86, 100C	2012
1309-37-1	Ferric oxide	3	1, Sup 7	1987
1309-64-4	Antimony trioxide	2B	47	1989
1314-62-1	Vanadium pentoxide	2B	86	2006
1317-60-8	Haematite	3	1, Sup 7	1987
1318-02-1	Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites)	3	68	1997
1330-20-7	Xylenes	3	47, 71	1999
1332-21-4 13768-00-8 12172-73-5 17068-78-9 12001-29-5 12001-28-4 14567-73-8	Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite)	1	14, Sup 7, 100C	2012	NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans
1333-86-4	Carbon black	2B	Sup 7, 65, 93	2010
1336-36-3	Polychlorinated biphenyls	1	18, Sup 7, 107	In prep.
1338-16-5	Iron sorbitol-citric acid complex	3	2, Sup 7	1987
1345-04-6	Antimony trisulfide	3	47	1989
1401-55-4	Tannic acid and tannins	3	10, Sup 7	1987
1402-68-2	Aflatoxins	1	56, 82, 100F, Sup 7	2012
1464-53-5	1,2:3,4-Diepoxybutane (see Monographs on 1,3-Butadiene)		11, Sup 7	1987
1582-09-8	Trifluralin	3	53	1991
1615-80-1	1,2-Diethylhydrazine	2B	4, Sup 7, 71	1999
1634-04-4	Methyl tert-butyl ether	3	73	1999
1675-54-3	Bisphenol A diglycidyl ether (Araldite)	3	47, 71	1999
1689-82-3	4-Hydroxyazobenzene	3	8, Sup 7	1987
1694-09-3	Benzyl violet 4B	2B	16, Sup 7	1987
1705-85-7	6-Methylchrysene	3	Sup 7, 92	2010
1706-01-0	3-Methylfluoranthene	3	Sup 7, 92	2010
1746-01-6	2,3,7,8-Tetrachlorodibenzo-para-dioxin	1	Sup 7, 69, 100F	2012
1836-75-5	Nitrofen (technical-grade)	2B	30, Sup 7	1987
1897-45-6	Chlorothalonil	2B	Sup 7, 73	1999
1912-24-9	Atrazine	3	53, 73	1999	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
1918-02-1	Picloram	3	53	1991
1936-15-8	CI Orange G	3	8, Sup 7	1987
1936-15-8	Orange G (see CI Orange G)
1937-37-7	CI Direct Black 38 (see Benzidine, dyes metabolized to)
1954-28-5	Triethylene glycol diglycidyl ether	3	11, Sup 7, 71	1999
2068-78-2	Vincristine sulfate	3	26, Sup 7	1987
2164-17-2	Fluometuron	3	30, Sup 7	1987
2168-68-5	Bis(1-aziridinyl)morpholinophosphine sulfide	3	9, Sup 7	1987
2243-62-1	1,5-Naphthalenediamine	3	27, Sup 7	1987
2303-16-4	Diallate	3	30, Sup 7	1987
2318-18-5	Senkirkine	3	31, Sup 7	1987
2353-45-9	Fast Green FCF	3	16, Sup 7	1987
2385-85-5	Mirex	2B	20, Sup 7	1987
2386-90-5	Bis(2,3-epoxycyclopentyl)ether	3	47, 71	1999
2425-06-1	Captafol	2A	53	1991	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
2425-85-6	CI Pigment Red 3	3	57	1993
2429-74-5	CI Direct Blue 15	2B	57	1993
2432-99-7	11-Aminoundecanoic acid	3	39, Sup 7	1987
2475-45-8	Disperse Blue 1	2B	48	1990
2602-46-2	CI Direct Blue 6 (see Benzidine, dyes metabolized to)
2646-17-5	Oil Orange SS	2B	8, Sup 7	1987
2757-90-6	Agaritine	3	31, Sup 7	1987
2783-94-0	Sunset Yellow FCF	3	8, Sup 7	1987
2784-94-3	HC Blue No. 1	2B	57	1993
2832-40-8	Disperse Yellow 3	3	48	1990
2835-39-4	Allyl isovalerate	3	36, Sup 7, 71	1999
2871-01-4	HC Red No. 3	3	57	1993
2955-38-6	Prazepam	3	66	1996
2973-10-6	Diisopropyl sulfate	2B	54, 71	1999
3018-12-0	Dichloroacetonitrile	3	52, 71	1999
3068-88-0	beta-Butyrolactone	2B	11, Sup 7, 71	1999
3118-97-6	Sudan II	3	8, Sup 7	1987
3173-72-6	1,5-Naphthalene diisocyanate	3	19, Sup 7, 71	1999
3252-43-5	Dibromoacetonitrile	2B	52, 71, 101	2013
3296-90-0	2,2-Bis(bromomethyl)propane-1,3-diol	2B	77	2000
3351-28-8	1-Methylchrysene	3	Sup 7, 92	2010
3351-30-2	4-Methylchrysene	3	Sup 7, 92	2010
3351-31-3	3-Methylchrysene	3	Sup 7, 92	2010
3351-32-4	2-Methylchrysene	3	Sup 7, 92	2010
3564-09-8	Ponceau 3R	2B	8, Sup 7	1987
3567-69-9	Carmoisine	3	8, Sup 7	1987
3570-75-0	2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole	2B	7, Sup 7	1987
3688-53-7	AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide]	2B	31, Sup 7	1987
3697-24-3	5-Methylchrysene	2B	Sup 7, 92	2010
3761-53-3	Ponceau MX	2B	8, Sup 7	1987
3771-19-5	Nafenopin	2B	24, Sup 7	1987
3778-73-2	Isophosphamide	3	26, Sup 7	1987
3795-88-8	5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)­amino]-2-oxazolidinone	2B	7, Sup 7	1987
3844-45-9	Brilliant Blue FCF, disodium salt	3	16, Sup 7	1987
3902-71-4	4,5′,8-Trimethylpsoralen	3	40, Sup 7	1987
4063-41-6	4,5′-Dimethylangelicin plus ultraviolet A radiation	3	Sup 7	1987
4170-30-3	Crotonaldehyde	3	63	1995
4342-03-4	Dacarbazine	2B	26, Sup 7	1987
4548-53-2	Ponceau SX	3	8, Sup 7	1987
4549-40-0	N-Nitrosomethylvinylamine	2B	17, Sup 7	1987
4657-93-6	5-Aminoacenaphthene	3	16, Sup 7	1987
4680-78-8	Guinea Green B	3	16, Sup 7	1987
5131-60-2	4-Chloro-meta-phenylenediamine	3	27, Sup 7	1987
5141-20-8	Light Green SF	3	16, Sup 7	1987
5160-02-1	D & C Red No. 9	3	Sup 7, 57	1993
5307-14-2	1,4-Diamino-2-nitrobenzene	3	Sup 7, 57	1993
5385-75-1	Dibenzo[a,e]fluoranthene	3	Sup 7, 92	2010
5431-33-4	Glycidyl oleate	3	11, Sup 7	1987
5456-28-0	Ethyl selenac	3	12, Sup 7	1987
5522-43-0	1-Nitropyrene	2A	Sup 7, 46, 105	2014	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
5589-96-8	Bromochloroacetic acid	2B	101	2013
5989-27-5	d-Limonene	3	56, 73	1999	NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
6164-98-3	Chlordimeform	3	30, Sup 7	1987
6358-53-8	Citrus Red No. 2	2B	8, Sup 7	1987
6368-72-5	Sudan Red 7B	3	8, Sup 7	1987
6373-74-6	CI Acid Orange 3	3	57	1993
6416-57-5	Sudan Brown RR	3	8, Sup 7	1987
6459-94-5	CI Acid Red 114	2B	57	1993
6795-23-9	Aflatoxin M1	2B	56	1993
6870-67-3	Jacobine	3	10, Sup 7	1987
7099-43-6	5,6-Cyclopenteno-1,2-benzanthracene	3	92	2010
7220-79-3	Methylene blue	3	108	In prep.
7439-92-1	Lead	2B	23, Sup 7	1987
7439-97-6	Mercury and inorganic mercury compounds	3	58	1993
7440-02-0	Nickel, metallic and alloys	2B	Sup 7, 49	1990
7440-07-5	Plutonium	1	78, 100D	2012
7440-29-1	Thorium-232 and its decay products	1	78, 100D	2012
7440-38-2	Arsenic and inorganic arsenic compounds	1	23, Sup 7, 100C	2012
7440-41-7	Beryllium and beryllium compounds	1	Sup 7, 58, 100C	2012
7440-43-9	Cadmium and cadmium compounds	1	58, 100C	2012
7440-47-3	Chromium, metallic	3	Sup 7, 49	1990
7440-48-4	Cobalt and cobalt compounds	2B	52	1991	NB: Evaluated as a group
7440-48-4	Cobalt metal without tungsten carbide	2B	86	2006
7440-48-4 12070-12-1	Cobalt metal with tungsten carbide	2A	86	2006
7446-09-5	Sulfur dioxide	3	54	1992
7460-84-6	Glycidyl stearate	3	11, Sup 7	1987
7481-89-2	Zalcitabine	2B	76	2000
7496-02-8	6-Nitrochrysene	2A	Sup 7, 46, 105	2014	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
7519-36-0	N-Nitrosoproline	3	17, Sup 7	1987
7572-29-4	Dichloroacetylene	3	39, Sup 7, 71	1999
7631-86-9	Silica, amorphous	3	Sup 7, 68	1997
7647-01-0	Hydrochloric acid	3	54	1992
7664-93-9	Strong-inorganic-acid mists containing sulfuric acid (see Acid mists)
7722-84-1	Hydrogen peroxide	3	36, Sup 7, 71	1999
7758-01-2	Potassium bromate	2B	Sup 7, 73	1999
7758-19-2	Sodium chlorite	3	52	1991
7782-49-2	Selenium and selenium compounds	3	9, Sup 7	1987
8001-35-2	Toxaphene (Polychlorinated camphenes)	2B	Sup 7, 79	2001
8001-50-1	Terpene polychlorinates (Strobane®)	3	5, Sup 7	1987
8001-58-9	Creosotes	2A	Sup 7, 92	2010
8002-05-9	Crude oil	3	45	1989
8007-45-2	Coal tars (see Coal-tar distillation)		35, Sup 7	1987
8007-45-2	Coal-tar distillation	1	92, 100F	2012
8018-07-3	Acriflavinium chloride	3	13, Sup 7	1987
8047-67-4	Saccharated iron oxide	3	2, Sup 7	1987
8052-42-4	Bitumens, extracts of steam-refined and air-refined; steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures)		35, Sup 7	1987
8052-42-4 64741-56-6	Bitumens, occupational exposure to straight-run bitumens and their emissions during road paving	2B	103	2013
9000-07-1	Carrageenan, native	3	31, Sup 7	1987
9000-38-8	Kava extract	2B	108	In prep.
9002-84-0	Polytetrafluoroethylene	3	19, Sup 7	1987
9002-86-2	Polyvinyl chloride	3	19, Sup 7	1987
9002-88-4	Polyethylene	3	19, Sup 7	1987
9002-89-5	Polyvinyl alcohol	3	19, Sup 7	1987
9003-01-4	Polyacrylic acid	3	19, Sup 7	1987
9003-07-0	Polypropylene	3	19, Sup 7	1987
9003-20-7	Polyvinyl acetate	3	19, Sup 7	1987
9003-22-9	Vinyl chloride-vinyl acetate copolymers	3	19, Sup 7	1987
9003-39-8	Polyvinyl pyrrolidone	3	19, Sup 7, 71	1987
9003-53-6	Polystyrene	3	19, Sup 7	1987
9003-54-7	Styrene-acrylonitrile copolymers	3	19, Sup .7	1987
9003-55-8	Styrene-butadiene copolymers	3	19, Sup 7	1987
9004-51-7	Iron-dextrin complex	3	2, Sup 7	1987
9004-66-4	Iron-dextran complex	2B	2, Sup 7	1987
9009-54-5	Polyurethane foams	3	19, Sup 7	1987
9010-98-4	Polychloroprene	3	19, Sup 7	1987
9011-06-7	Vinylidene chloride-vinyl chloride copolymers	3	19, Sup 7	1987
9011-14-7	Polymethyl methacrylate	3	19, Sup 7	1987
9016-87-9	Polymethylene polyphenyl isocyanate	3	19, Sup 7	1987
10026-24-1	Cobalt sulfate and other soluble cobalt(II) salts	2B	86	2006
10043-66-0	Iodine-131 (see Radioiodines)
10043-92-2	Radon-222 and its decay products	1	43, 78, 100D	2012
10048-13-2	Sterigmatocystin	2B	10, Sup 7	1987
10048-32-5	Parasorbic acid	3	10, Sup 7	1987
10098-97-2	Strontium-90 (see Fission products)
10380-28-6	Copper 8-hydroxyquinoline	3	15, Sup 7	1987
10540-29-1	Tamoxifen	1	66, 100A	2012	NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients
10595-95-6	N-Nitrosomethylethylamine	2B	17, Sup 7	1987
10599-90-3	Chloramine	3	84	2004
11056-06-7	Bleomycins	2B	26, Sup 7	1987	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
12001-79-5	Vitamin K substances	3	76	2000
12070-12-1 7440-48-4	Tungsten carbide with cobalt metal (see Cobalt metal with tungsten carbide)
12122-67-7	Zineb	3	12, Sup 7	1987
12174-11-7	Attapulgite (see Palygorskite)
12174-11-7	Palygorskite (Attapulgite) (long fibres, > 5 micrometres)	2B	68	1997
12174-11-7	Palygorskite (Attapulgite)(short fibres, < 5 micrometres)	3	68	1997
12192-57-3	Aurothioglucose	3	13, Sup 7	1987
12427-38-2	Maneb	3	12, Sup 7	1987
12663-46-6	Cyclochlorotine	3	10, Sup 7	1987
13010-47-4	1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)	2A	26, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
13045-94-8	Medphalan	3	9, Sup 7	1987
13233-32-4	Radium-224 and its decay products	1	78, 100D	2012
13256-22-9	N-Nitrososarcosine	2B	17, Sup 7	1987
13292-46-1	Rifampicin	3	24, Sup 7	1987
13463-67-7	Titanium dioxide	2B	47, 93	2010
13483-18-6	1,2-Bis(chloromethoxy)ethane	3	15; Sup 7, 71	1999
13909-09-6	1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) (see Semustine)
13909-09-6	Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, Methyl-CCNU]	1	Sup 7, 100A	2012
13982-63-3	Radium-226 and its decay products	1	78, 100D	2012
13983-17-0	Wollastonite	3	Sup 7, 68	1997
14484-64-1	Ferbam	3	12, Sup 7	1987
14596-37-3	Phosphorus-32, as phosphate	1	78, 100D	2012
14807-96-6	Talc containing asbestiform fibres (see Asbestos)		42, Sup 7	1987
14807-96-6	Talc not containing asbestos or asbestiform fibres	3	42, Sup 7, 93	2010
14807-96-6	Talc-based body powder (perineal use of)	2B	93	2010
14808-60-7	Silica dust, crystalline, in the form of quartz or cristobalite	1	Sup 7, 68, 100C	2012
14901-08-7	Cycasin	2B	10, Sup 7	1987
15086-94-9	Eosin	3	15, Sup 7	1987
15262-20-1	Radium-228 and its decay products	1	78, 100D	2012
15501-74-3	Sepiolite	3	Sup 7, 68	1997
15503-86-3	Isatidine	3	10, Sup 7	1987
15663-27-1	Cisplatin	2A	26, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
15721-02-5	2,2′,5,5′-Tetrachlorobenzidine	3	27, Sup 7	1987
16065-83-1	Chromium (III) compounds	3	49	1990
16071-86-6	CI Direct Brown 95 (see Benzidine, dyes metabolized to)
16543-55-8 64091-91-4	N‘-Nitrosonornicotine (NNN) and 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK)	1	Sup 7, 89, 100E	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
16568-02-8	Gyromitrin	3	31, Sup 7	1987
16984-48-8	Fluorides (inorganic, used in drinking-water)	3	27, Sup 7	1987
17117-34-9	3-Nitrobenzanthrone	2B	105	2014	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
18540-29-9	Chromium (VI) compounds	1	Sup 7, 49, 100C	2012
18883-66-4	Streptozotocin	2B	17, Sup 7	1987
20073-24-9	3-Carbethoxypsoralen	3	40, Sup 7	1987
20268-51-3	7-Nitrobenz[a]anthracene	3	46	1989
20589-63-3	3-Nitroperylene	3	46	1989
20830-75-5	Digoxin	2B	108	In prep.
20830-81-3	Daunomycin	2B	10, Sup 7	1987
20941-65-5	Ethyl tellurac	3	12, Sup 7	1987
21884-44-6	Luteoskyrin	3	10, Sup 7	1987
22248-79-9	Tetrachlorvinphos	2B	30, Sup 7, 112	In prep.
22349-59-3	1,4-Dimethylphenanthrene	3	Sup 7, 92	2010
22398-80-7	Indium phosphide	2A	86	2006	NB: Overall evaluation upgraded to Group 2A
22506-53-2	3,9-Dinitrofluoranthene	2B	46, 65, 105	2013
22571-95-5	Symphytine	3	31, Sup 7	1987
22966-79-6	Oestradiol mustard	3	9, Sup 7	1987
22975-76-4	4,4′-Dimethylangelicin plus ultraviolet A radiation	3	Sup 7	1987
23214-92-8	Adriamycin	2A	10, Sup 7	1987	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
23246-96-0	Riddelliine	2B	10, Sup 7, 82	2002
23255-93-8	Hycanthone mesylate	3	13, Sup 7	1987
23537-16-8	Rugulosin	3	40, Sup 7	1987
23746-34-1	Potassium bis(2-hydroxyethyl)dithiocarbamate	3	12, Sup 7	1987
24560-98-3	cis-9,10-Epoxystearic acid	3	11, Sup 7, 71	1999
24938-64-5	para-Aramid fibrils	3	68	1997
25013-15-4	Vinyl toluene	3	60	1994
25013-16-5	Butylated hydroxyanisole (BHA)	2B	40, Sup 7	1987
25038-54-4	Nylon 6	3	19, Sup 7	1987
25732-74-5	Acepyrene (3,4-dihydrocyclopenta[cd]pyrene)	3	92	2010
25812-30-0	Gemfibrozil	3	66	1996
25962-77-0	trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole	2B	7, Sup 7	1987
26148-68-5	A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)	2B	40, Sup 7	1987
26308-28-1	Ripazepam	3	66	1996
26471-62-5	Toluene diisocyanates	2B	39, Sup 7, 71	1999
26782-43-4	Hydroxysenkirkine	3	10, Sup 7	1987
27208-37-3	Cyclopenta[cd]pyrene	2A	Sup 7, 92	2010	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
28434-86-8	3,3′-Dichloro-4,4′-diaminodiphenyl ether	2B	16, Sup 7	1987
29069-24-7	Prednimustine	3	50	1990
29291-35-8	N-Nitrosofolic acid	3	17, Sup 7	1987
29767-20-2	Teniposide	2A	76	2000	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
29975-16-4	Estazolam	3	66	1996
30310-80-6	N-Nitrosohydroxyproline	3	17, Sup 7	1987
30516-87-1	Zidovudine (AZT)	2B	76	2000
33229-34-4	HC Blue No. 2	3	57	1993
33419-42-0	Etoposide	1	76, 100A	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
33419-42-0 15663-27-1 11056-06-7	Etoposide in combination with cisplatin and bleomycin	1	76, 100A	2012
33543-31-6	2-Methylfluoranthene	3	Sup 7, 92	2010
37319-17-8	Pentosan polysulfate sodium	2B	108	In prep.
37620-20-5	N‘-Nitrosoanabasine (NAB)	3	37, Sup 7, 89	2007
38571-73-2	1,2,3-Tris(chloromethoxy)propane	3	15, Sup 7, 71	1999
40762-15-0	Doxefazepam	3	66	1996
42397-64-8	1,6-Dinitropyrene	2B	46, 105	2013
42397-65-9	1,8-Dinitropyrene	2B	Sup 7, 46, 105	2013
51264-14-3	Amsacrine	2B	76	2000
51481-61-9	Cimetidine	3	50	1990
51630-58-1	Fenvalerate	3	53	1991
52645-53-1	Permethrin	3	53	1991
52918-63-5	Deltamethrin	3	53	1991
53973-98-1	Carrageenan, degraded (Poligeenan)	2B	31, Sup 7	1987
53973-98-1	Poligeenan (see Carrageenan, degraded)
54749-90-5	Chlorozotocin	2A	50	1990	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55557-01-2	N-Nitrosoguvacine	3	Sup 7, 85	2004
55557-02-3	N-Nitrosoguvacoline	3	Sup 7, 85	2004
56894-91-8	1,4-Bis(chloromethoxymethyl)benzene	3	15; Sup 7, 71	1999
57018-52-7	1-tert-Butoxypropan-2-ol	3	88	2006
57117-31-4	2,3,4,7,8-Pentachlorodibenzofuran	1	100F	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
57465-28-8	3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126)	1	100F	2012	See Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO
57835-92-4	4-Nitropyrene	2B	46, 105	2013
59277-89-3	Aciclovir	3	76	2000
59536-65-1	Polybrominated biphenyls	2A	41, Sup 7, 107	In prep.	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1
59820-43-8	HC Yellow No. 4	3	57	1993
59865-13-3 79217-60-0	Ciclosporin (see Cyclosporine)
59865-13-3 79217-60-0	Cyclosporine	1	50, 100A	2012
60102-37-6	Petasitenine	3	31, Sup 7	1987
60153-49-3	3-(N-Nitrosomethylamino)propionitrile	2B	Sup 7, 85	2004
62450-06-0	Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole)	2B	31, Sup 7	1987
62450-07-1	Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole)	2B	31, Sup 7	1987
63041-90-7	6-Nitrobenzo[a]pyrene	3	Sup 7, 46	1989
64436-13-1	Arsenobetaine and other organic arsenic compounds that are not metabolized in humans	3	100C	2012
64742-93-4	Bitumens, occupational exposure to oxidized bitumens and their emissions during roofing	2A	103	2013
65271-80-9	Mitoxantrone	2B	76	2000
65996-93-2	Coal-tar pitch	1	35, Sup 7, 100F	2012
66733-21-9	Erionite	1	42, Sup 7, 100C	2012
67730-10-3	Glu-P-2 (2-Aminodipyrido[1,2-a:3′,2′-d]imidazole)	2B	40, Sup 7	1987
67730-11-4	Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole)	2B	40, Sup 7	1987
68006-83-7	MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)	2B	40, Sup 7	1987
68308-34-9	Shale oils	1	35, Sup 7, 100F	2012
68603-42-9	Coconut oil diethanolamine condensate	2B	101	2013
69655-05-6	Didanosine	3	76	2000
71267-22-6	N‘-Nitrosoanatabine (NAT)	3	37, Sup 7, 89	2007
73459-03-7	5-Methylangelicin plus ultraviolet A radiation	3	Sup 7	1987
75321-20-9	1,3-Dinitropyrene	2B	46, 105	2013
76180-96-6	IQ (2-Amino-3-methylimidazo[4,5-f]quinoline)	2A	Sup 7, 56	1993	NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
77094-11-2	MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline)	2B	Sup 7, 56	1993
77439-76-0	3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	2B	84	2004
77500-04-0	MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline)	2B	Sup 7, 56	1993
82413-20-5	Droloxifene	3	66	1996
83463-62-1	Bromochloroacetonitrile	3	52, 71	1999
85502-23-4	3-(N-Nitrosomethylamino)propionaldehyde	3	Sup 7, 85	2004
85878-62-2	Pyrido[3,4-c]psoralen	3	40, Sup 7	1987
85878-63-3	7-Methylpyrido[3,4-c]psoralen	3	40, Sup 7	1987
87625-62-5	Ptaquiloside	3	40, Sup 7	1987
89778-26-7	Toremifene	3	66	1996
90045-36-6	Ginkgo biloba extract	2B	108	In prep.
90370-29-9	4,4′,6-Trimethylangelicin plus ultraviolet A radiation	3	Sup 7	1987
90456-67-0 [deleted] 924-42-5	N-Methylolacrylamide	3	60	1994
101043-37-2	Microcystin-LR	2B	94	2010
105650-23-5	PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)	2B	56	1993
105735-71-5	3,7-Dinitrofluoranthene	2B	46, 65, 105	2013
111025-46-8	Pioglitazone	2A	108	In prep.
111189-32-3	Naphtho[1,2-b]fluoranthene	3	92	2010
116355-83-0	Fumonisin B1	2B	82	2002
116355-83-0	Fusarium moniliforme, toxins derived from (fumonisin B1, fumonisin B2, and fusarin C)	2B	56	1993
118399-22-7	Nodularins	3	94	2010
122320-73-4	Rosiglitazone	3	108	In prep.
308068-56-6	Carbon nanotubes, multi-walled MWCNT-7	2B	111	In prep.
308068-56-6	Carbon nanotubes, multi-walled, other than MWCNT-7	3	111	In prep.
308068-56-6	Carbon nanotubes, single-walled	3	111	In prep.
308068-56-6	Multi-walled carbon nanotubes MWCNT-7 (see Carbon nanotubes, multi-walled MWCNT-7)
308068-56-6	Multi-walled carbon nanotubes other than MWCNT-7 (see Carbon nanotubes, multi-walled, other than MWCNT-7)
308068-56-6	Single-walled carbon nanotubes (see Carbon nanotubes, single-walled)
308076-74-6	Silicon carbide, fibrous	2B	111	In prep.
409-21-2	Silicon carbide whiskers	2A	111	In prep.
	Acheson process, occupational exposure associated with	1	111	In prep.
	Acid mists, strong inorganic	1	54, 100F	2012
	Acrylic fibres	3	19, Sup 7	1987
	Acrylonitrile-butadiene-styrene copolymers	3	19, Sup 7	1987
	Alcoholic beverages	1	44, 96, 100E	2012
	Aloe vera, whole leaf extract	2B	108	In prep.
	Alpha particles (see Radionuclides)
	Aluminium production	1	34, Sup 7, 92, 100F	2012
	Anaesthetics, volatile	3	11, Sup 7	1987
	Androgenic (anabolic) steroids	2A	Sup 7	1987
	Areca nut	1	85, 100E	2012
	Art glass, glass containers and pressed ware (manufacture of)	2A	58	1993
	Auramine production	1	Sup 7, 99, 100F	2012
	Benzidine, dyes metabolized to	1	99, 100F	2012	NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
	Beta particles (see Radionuclides)
	Betel quid with tobacco	1	Sup 7, 85, 100E	2012
	Betel quid without tobacco	1	Sup 7, 85, 100E	2012
	Biomass fuel (primarily wood), indoor emissions from household combustion of	2A	95	2010
	Bisulfites	3	54	1992
	Bitumens, occupational exposure to hard bitumens and their emissions during mastic asphalt work	2B	103	2013
	BK polyomavirus (BKV)	2B	104	2013
	Boot and shoe manufacture and repair (see Leather dust, Benzene)		25, Sup 7	1987
	Bracken fern	2B	40, Sup 7	1987
	Calcium carbide production	3	92	2010
	Carbon electrode manufacture	2A	92	2010
	Carpentry and joinery	2B	25, Sup 7	1987
	Chimney sweeping (see Soot)		92	2010
	Chlorinated drinking-water	3	52	1991
	Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60%	2B	48	1990
	Chlorophenols (see Polychlorophenols)
	Chlorophenoxy herbicides	2B	41, Sup 7	1987
	Clonorchis sinensis (infection with)	1	61, 100B	2012
	Coal dust	3	68	1997
	Coal gasification	1	Sup 7, 92, 100F	2012
	Coal, indoor emissions from household combustion of	1	95, 100E	2012
	Coffee (urinary bladder)	2B	51	1991	NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs
	Coke production	1	Sup 7, 92, 100F	2012
	Continuous glass filament (see Glass filament)
	Diesel engine exhaust (see Engine exhaust, diesel)
	Diesel fuel, marine	2B	45	1989	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
	Diesel fuels, distillate (light)	3	45	1989
	Dry cleaning (occupational exposures in)	2B	63	1995
	Dyes metabolized to benzidine (see Benzidine, dyes metabolized to)
	Electric fields, extremely low-frequency	3	80	2002
	Electric fields, static	3	80	2002
	Engine exhaust, diesel	1	46, 105	2013
	Engine exhaust, gasoline	2B	46, 105	2013
	Epstein-Barr virus	1	70, 100B	2012
	Estrogen therapy, postmenopausal	1	72, 100A	2012
	Estrogen-progestogen menopausal therapy (combined)	1	72, 91, 100A	2012
	Estrogen-progestogen oral contraceptives (combined)	1	72, 91, 100A	2012	NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary
	Firefighter (occupational exposure as a)	2B	98	2010
	Fission products, including strontium-90	1	100D	2012
	Flat-glass and specialty glass (manufacture of)	3	58	1993
	Fluorescent lighting	3	55	1992
	Fluoro-edenite fibrous amphibole	1	111	In prep.
	Foreign bodies (see Surgical implants and other foreign bodies)
	Frying, emissions from high-temperature	2A	95	2010
	Fuel oils, distillate (light)	3	45	1989
	Fuel oils, residual (heavy)	2B	45	1989
	Furniture and cabinet making (see Wood dust)		25, Sup 7	1987
	Fusarium graminearum, F. culmorum, andF. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X)	3	Sup 7, 56	1993
	Fusarium sporotrichioides, toxins derived from (T-2 toxin)	3	56	1993
	Gamma-Radiation (see X- and Gamma-Radiation)
	Gasoline	2B	45	1989	NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
	Gasoline engine exhaust (see Engine exhaust, gasoline)
	Glass filament, continuous	3	43, 81	2002
	Goldenseal root powder	2B	108	In prep.
	Haematite mining (underground)	1	1, Sup 7, 100D	2012
	Hair colouring products (personal use of)	3	57, 99	2010
	Hairdresser or barber (occupational exposure as a)	2A	57, 99	2010
	Helicobacter pylori (infection with)	1	61, 100B	2012
	Hepatitis B virus (chronic infection with)	1	59, 100B	2012
	Hepatitis C virus (chronic infection with)	1	59, 100B	2012
	Hepatitis D virus	3	59	1994
	Hexachlorocyclohexanes	2B	20, Sup 7	1987
	High-temperature frying (see Frying)
	Hot mate (see Mate, hot)
	Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of)
	Household combustion of coal (see Coal, indoor emissions from household combustion)
	Human herpesvirus type 4 (see Epstein-Barr virus)
	Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus)
	Human immunodeficiency virus type 1 (infection with)	1	67, 100B	2012
	Human immunodeficiency virus type 2 (infection with)	2B	67	1996
	Human papillomavirus genus beta (except types 5 and 8) and genus gamma	3	90, 100B	2012
	Human papillomavirus type 68	2A	100B	2012
	Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59	1	64, 90, 100B	2012	NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer
	Human papillomavirus types 26, 53, 66, 67, 70, 73, 82	2B	100B	2012
	Human papillomavirus types 30, 34, 69, 85, 97	2B	100B	2012	NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1
	Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis)	2B	100B	2012
	Human papillomavirus types 6 and 11	3	90, 100B	2012
	Human T-cell lymphotropic virus type I	1	67, 100B	2012
	Human T-cell lymphotropic virus type II	3	67	1996
	Hypochlorite salts	3	52	1991
	Insulation glass wool	3	43, 81	2002
	Involuntary smoking (see Tobacco smoke, second-hand)
	Ionizing radiation (all types)	1	100D	2012
	Iron and steel founding (occupational exposure during)	1	34, Sup 7, 100F	2012
	Isopropyl alcohol manufacture using strong acids	1	Sup 7, 100F	2012
	Isopropyl oils	3	15, Sup 7, 71	1999
	JC polyomavirus (JCV)	2B	104	2013
	Jet fuel	3	45	1989
	Kaposi sarcoma herpesvirus	1	70, 100B	2012
	Lead compounds, inorganic	2A	Sup 7, 87	2006
	Lead compounds, organic	3	23, Sup 7, 87	2006	NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead
	Leather dust	1	100C	2012
	Leather goods manufacture	3	25, Sup 7	1987
	Leather tanning and processing	3	25, Sup 7	1987
	Lumber and sawmill industries (including logging)	3	25, Sup 7	1987
	Madder root (Rubia tinctorum)	3	82	2002
	Magenta production	1	Sup 7, 57, 99, 100F	2012
	Magnetic fields, extremely low-frequency	2B	80	2002
	Magnetic fields, static	3	80	2002
	Malaria (caused by infection withPlasmodium falciparum in holoendemic areas)	2A	104	2013
	Mate	3	51	1991
	Mate, hot	2A	51	1991
	Merkel cell polyomavirus (MCV)	2A	104	2013
	Metabisulfites	3	54	1992
	Methylmercury compounds	2B	58	1993	NB: Evaluated as a group
	Microcystis extracts	3	94	2010
	Mineral oils, highly-refined	3	33, Sup 7	1987
	Mineral oils, untreated or mildly treated	1	33, Sup 7, 100F	2012
	Modacrylic fibres	3	19, Sup 7	1987
	MOPP and other combined chemotherapy including alkylating agents	1	Sup 7, 100A	2012
	Neutron radiation	1	75, 100D	2012	NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
	Nickel compounds	1	Sup 7, 49, 100C	2012
	Nickel refining (see Nickel compounds)		11	1976
	Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation	2A	94	2010
	Non-arsenical insecticides (occupational exposures in spraying and application of)	2A	53	1991
	Oestrogen (see Estrogen)
	Opisthorchis felineus (infection with)	3	61	1994
	Opisthorchis viverrini (infection with)	1	61, 100B	2012
	Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives)
	Outdoor air pollution	1	109	In prep.
	Outdoor air pollution, particulate matter in	1	109	In prep.
	Paint manufacture (occupational exposure in)	3	47	1989
	Painter (occupational exposure as a)	1	47, 98, 100F	2012
	Particulate matter in outdoor air pollution (see Outdoor air pollution, particulate matter in)
	Paving and roofing with coal-tar pitch (see Coal-tar pitch)		35, Sup 7, 92, 100F	2010
	Petroleum refining (occupational exposures in)	2A	45	1989
	Petroleum solvents	3	47	1989
	Phenacetin, analgesic mixtures containing	1	Sup 7, 100A	2012
	Pickled vegetables (traditional Asian)	2B	56	1993
	Polychlorinated biphenyls, dioxin-like, with a Toxicity Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189)	1	107	In prep.	NB: Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data
	Polychlorinated dibenzofurans (see 2,3,4,7,8-Pentachlorodibenzofuran)	3	69	1997
	Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8-tetrachlorodibenzo-para-dioxin)	3	69	1997
	Polychlorophenols and their sodium salts (mixed exposures)	2B	53, 71	1999
	Printing inks	3	65	1996
	Printing processes (occupational exposures in)	2B	65	1996
	Processed meat (consumption of)	1	114	In prep.
	Proflavine salts	3	24, Sup 7	1987
	Progestins	2B	Sup 7	1987
	Progestogen-only contraceptives	2B	72	1999
	Pulp and paper manufacture	3	25, Sup 7	1987
	Radiofrequency electromagnetic fields	2B	102	2013
	Radioiodines, including iodine-131	1	78, 100D	2012
	Radionuclides, alpha-particle-emitting, internally deposited	1	78, 100D	2012	NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
	Radionuclides, beta-particle-emitting, internally deposited	1	78, 100D	2012	NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
	Red Meat (consumption of)	2A	114	In prep.
	Refractory ceramic fibres	2B	43, 81	2002
	Rock (stone) wool	3	43, 81	2002
	Rubber manufacturing industry	1	28, Sup 7, 100F	2012
	Salted fish, Chinese-style	1	56, 100E	2012
	Schistosoma haematobium (infection with)	1	61, 100B	2012
	Schistosoma japonicum (infection with)	2B	61	1994
	Schistosoma mansoni (infection with)	3	61	1994
	Shiftwork that involves circadian disruption	2A	98	2010
	Slag wool	3	43, 81	2002
	Solar radiation	1	55, 100D	2012
	Soot (as found in occupational exposure of chimney sweeps)	1	35, Sup 7, 92, 100F	2012
	Special-purpose fibres such as E-glass and ‘475’ glass fibres	2B	81	2002
	Sulfites	3	54	1992
	Sunlamps and sunbeds (see Ultraviolet-emitting tanning devices)
	Surgical implants and other foreign bodies: – Organic polymeric materials (as a group) – Orthopaedic implants of complex composition – Cardiac pacemakers – Silicone breast implants – Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium – Dental materials – Ceramic implants	3	74	1999
	Surgical implants and other foreign bodies: – Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid)) – Metallic implants prepared as thin smooth films – Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron	2B	74	1999
	SV40 polyomavirus	3	104	2013
	Tea	3	51	1991
	Tetrakis(hydroxymethyl)phosphonium salts	3	48, 71	1999
	Textile manufacturing industry (work in)	2B	48	1990
	Tobacco smoke, second-hand	1	83, 100E	2012
	Tobacco smoking	1	83, 100E	2012
	Tobacco, smokeless	1	Sup 7, 89, 100E	2012
	Toxins derived from certain Fusariumspecies (see Fusarium)
	Ultraviolet radiation (wavelengths 100-400 nm, encompassing UVA, UVB, and UVC)	1	55, 100D	2012
	Ultraviolet-emitting tanning devices	1	100D	2012
	Urethane (see Ethyl carbamate)
	Welding fumes	2B	49	1990	NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders
	Wood dust	1	62, 100C	2012
	Wood smoke (see Biomass fuel, indoor emissions from household combustion)
	X- and Gamma-Radiation	1	75, 100D	2012